ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Rheumatology

Top Rheumatology Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROVINDER SAINI MD

Rheumatology

10,597

$536K

513
381 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $140

JOSEPH COURI MD

Rheumatology

8,991

$749K

646
411 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 12%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $140

MARK STERN M.D.

Rheumatology

8,853

$895K

709
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $140

GOWHAR KHAN MD

Rheumatology

8,527

$457K

207
52 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

66%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $140

IRA FENTON DO

Rheumatology

8,417

$703K

439
338 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $140

ROBERT HOZMAN M.D.

Rheumatology

7,728

$555K

415
322 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $140

DENNIS OZMENT MD

Rheumatology

7,501

$705K

558
404 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $140

FRANCIS LICHON MD

Rheumatology

6,617

$900K

433
336 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

39%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $140

VAUGHN HANNA MD

Rheumatology

6,310

$441K

626
373 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $140

MICHAEL MINITER M.D.

Rheumatology

6,202

$846K

551
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $140

SATYENDRA HUMAD M.D.

Rheumatology

6,172

$471K

468
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $140

RAYMOND KAZMAR M.D.

Rheumatology

6,027

$890K

362
236 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $140

RICHARD OLSON M.D.

Rheumatology

5,953

$715K

502
364 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$120
Average prescription price

Avg: $140

MAJID SERUSHAN M.D.

Rheumatology

5,266

$619K

423
274 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$117
Average prescription price

Avg: $140

EDWARD ROSE MD

Rheumatology

5,206

$547K

396
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $140

NEHEMIAH TAN M.D.

Rheumatology

4,934

$442K

476
342 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $140

LEE LICHTENBERG MD

Rheumatology

4,903

$567K

395
299 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$116
Average prescription price

Avg: $140

DAVID DANSDILL M.D.

Rheumatology

4,838

$784K

567
454 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $140

SHRI AGRAWAL M.D.

Rheumatology

4,328

$628K

441
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $140

MICHAEL PICK M.D.

Rheumatology

4,293

$573K

382
283 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $140

ROBIN HOVIS MD

Rheumatology

4,020

$713K

445
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$177
Average prescription price

Avg: $140

ANDRZEJ JASEK MD

Rheumatology

3,849

$421K

269
129 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $140

ROBERT KATZ M.D.

Rheumatology

3,757

$438K

216
151 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$117
Average prescription price

Avg: $140

IQBAL AKHTER MD

Rheumatology

3,633

$801K

331
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$221
Average prescription price

Avg: $140

GERALD EISENBERG MD

Rheumatology

3,631

$512K

558
493 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$141
Average prescription price

Avg: $140

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank